{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:25:01Z","timestamp":1790670301792,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00277-022-04798-8","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:20:19Z","timestamp":1645474819000},"page":"1049-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study"],"prefix":"10.1007","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-4623","authenticated-orcid":false,"given":"Mehmet","family":"Baysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vildan","family":"G\u00fcrsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazil Cagri","family":"Hunutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buket","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedanur Karaman","family":"Gulsaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Ethem","family":"Pinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba","family":"Ersal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugcan Alp","family":"Kirkizlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Ikbal","family":"Atli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakki Onur","family":"Kirkizlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif G","family":"\u00dcmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"G\u00fcrkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vildan","family":"Ozkocaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahir","family":"Ozkalemkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Muzaffer","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridvan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"issue":"3","key":"4798_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.0954-6820.1957.tb00124.x","volume":"159","author":"LK Hillestad","year":"1957","unstructured":"Hillestad LK (1957) Acute promyelocytic leukemia. Acta med Scand 159(3):189\u2013194","journal-title":"Acta medica Scandinavica."},{"issue":"8010","key":"4798_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(77)91415-5","volume":"1","author":"JD Rowley","year":"1977","unstructured":"Rowley JD, Golomb HM, Dougherty C (1977) 15\/17 translocation, a consistent chromosomal change in acute promyelocytic leukemia. Lancet 1(8010):549\u2013550","journal-title":"Lancet (London, England)."},{"issue":"5","key":"4798_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0002-9343(84)90994-X","volume":"76","author":"RA Larson","year":"1984","unstructured":"Larson RA, Kondo K, Vardiman JW, Butler AE, Golomb HM,\u00a0Rowley JD\u00a0et al (1984)\u00a0Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med 76(5):827\u2013841","journal-title":"The American journal of medicine."},{"issue":"3","key":"4798_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2141.1996.d01-1004.x","volume":"94","author":"D Grimwade","year":"1996","unstructured":"Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H et al (1996) Establishing the presence of the t(15;17) in suspected acute promyelocytic leukemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. Br J Haematol 94(3):557\u2013573","journal-title":"Br J Haematol."},{"issue":"2","key":"4798_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","volume":"72","author":"ME Huang","year":"1988","unstructured":"Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L et al (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72(2):567\u2013572","journal-title":"Blood."},{"issue":"4","key":"4798_CR6","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1182\/blood.V88.4.1390.bloodjournal8841390","volume":"88","author":"G Avvisati","year":"1996","unstructured":"Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M et al (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A gruppo italiano malattie ematologiche maligne dell'adulto (GIMEMA) pilot study. Blood 88(4):1390\u20131398","journal-title":"Blood."},{"issue":"5","key":"4798_CR7","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1182\/blood-2011-04-346437","volume":"118","author":"JH Park","year":"2011","unstructured":"Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL et al (2011) Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood 118(5):1248\u20131254","journal-title":"Blood."},{"issue":"1","key":"4798_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3324\/haematol.2011.046490","volume":"97","author":"JS McClellan","year":"2012","unstructured":"McClellan JS, Kohrt HE, Coutre S, Gotlib JR, Majeti R, Alizadeh AA et al (2012) Treatment advances have not improved the early death rate in acute promyelocytic leukemia. Haematologica 97(1):133\u2013136","journal-title":"Haematologica."},{"issue":"8","key":"4798_CR9","first-page":"2712","volume":"92","author":"S De Botton","year":"1998","unstructured":"De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R et al (1998) Incidence, clinical features, and outcome of all-trans retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 92(8):2712\u20132718","journal-title":"The European APL Group. Blood."},{"issue":"1","key":"4798_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2141.2011.08922.x","volume":"156","author":"KA Breen","year":"2012","unstructured":"Breen KA, Grimwade D, Hunt BJ (2012) The pathogenesis and management of the coagulopathy of acute promyelocytic leukemia. Br J Haematol 156(1):24\u201336","journal-title":"Br J Haematol."},{"issue":"4","key":"4798_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.thromres.2014.11.026","volume":"135","author":"M Mitrovic","year":"2015","unstructured":"Mitrovic M, Suvajdzic N, Elezovic I, Bogdanovic A, Djordjevic V, Miljic P et al (2015) Thrombotic events in acute promyelocytic leukemia. Thromb Res 135(4):588\u2013593","journal-title":"Thromb Res."},{"issue":"1","key":"4798_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1182\/asheducation-2016.1.10","volume":"2016","author":"S Abedin","year":"2016","unstructured":"Abedin S, Altman JK (2016) Acute promyelocytic leukemia: preventing early complications and late toxicities. Hematol Am Soc Hematol Educ Prog\u00a02016(1):10\u201315","journal-title":"Hematology American Society of Hematology Education Program."},{"issue":"2","key":"4798_CR13","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1016\/j.clml.2018.11.004","volume":"19","author":"WFD Silva Jr","year":"2019","unstructured":"Silva WFD Jr, Rosa LID, Marquez GL, Bassolli L, Tucunduva L, Silveira DRA et al (2019) Real-life outcomes on acute promyelocytic leukemia in Brazil - early deaths are still a problem. Clin Lymphoma Myeloma Leuk 19(2):e116\u2013ee22","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"4","key":"4798_CR14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4103\/ijc.IJC_177_19","volume":"57","author":"KR Golamari","year":"2020","unstructured":"Golamari KR, Mikkilineni A, Chappidi S (2020) Early death in acute promyelocytic leukemia: evidence from a rural cancer center. Indian J Cancer 57(4):451\u2013456","journal-title":"Indian journal of cancer."},{"issue":"10","key":"4798_CR15","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3324\/haematol.10874","volume":"92","author":"RH J\u00e1como","year":"2007","unstructured":"J\u00e1como RH, Melo RA, Souto FR, de Mattos ER, de Oliveira CT, Fagundes EM et al (2007) Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica 92(10):1431\u20131432","journal-title":"Haematologica."},{"key":"4798_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1515\/med-2019-0074","volume":"14","author":"R Ciftciler","year":"2019","unstructured":"Ciftciler R, Haznedaroglu IC, Aksu S, Ozcebe O, Sayinalp N, Malkan UY et al (2019) The factors affecting early death in newly diagnosed APL patients. Open Med (Wars) 14:647\u2013652","journal-title":"Open Med (Wars)."},{"issue":"3","key":"4798_CR17","first-page":"142","volume":"13","author":"R Jeddi","year":"2008","unstructured":"Jeddi R, Kacem K, Ben Neji H, Mnif S, Gouider E, Aissaoui L et al (2008) Predictive factors of all-trans retinoic acid-related complications during induction therapy for acute promyelocytic leukemia. Hematology 13(3):142\u2013146","journal-title":"Hematology (Amsterdam, Netherlands)."},{"issue":"17","key":"4798_CR18","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1182\/blood-2010-03-276196","volume":"116","author":"F Lo-Coco","year":"2010","unstructured":"Lo-Coco F, Avvisati G, Vignetti M, Breccia M, Gallo E, Rambaldi A et al (2010) Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group. Blood 116(17):3171\u20133179","journal-title":"Blood."},{"issue":"6","key":"4798_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3904\/kjim.2015.30.6.884","volume":"30","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, Kim DH, Lee S, Koh MS, Kim SY, Lee JH et al (2015) Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia. Korean J Intern Med 30(6):884\u2013890","journal-title":"Korean J Intern Med."},{"issue":"6","key":"4798_CR20","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/leu.2017.71","volume":"31","author":"S Lehmann","year":"2017","unstructured":"Lehmann S, Deneberg S, Antunovic P, Rangert-Derolf \u00c5, Garelius H, Lazarevic V et al (2017) Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013. Leukemia 31(6):1457\u20131459","journal-title":"Leukemia."},{"issue":"13","key":"4798_CR21","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1182\/blood-2016-10-747170","volume":"129","author":"S Mantha","year":"2017","unstructured":"Mantha S, Goldman DA, Devlin SM, Lee JW, Zannino D, Collins M et al (2017) Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era. Blood 129(13):1763\u20131767","journal-title":"Blood."},{"issue":"11","key":"4798_CR22","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1182\/blood.V82.11.3241.3241","volume":"82","author":"P Fenaux","year":"1993","unstructured":"Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H et al (1993) Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood 82(11):3241\u20133249","journal-title":"Blood."},{"issue":"4","key":"4798_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1365-2141.2000.01936.x","volume":"108","author":"E Di Bona","year":"2000","unstructured":"Di Bona E, Avvisati G, Castaman G, Luce Vegna M, De Sanctis V, Rodeghiero F et al (2000) Early hemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukemia. Br J Haematol 108(4):689\u2013695","journal-title":"Br J Haematol."},{"issue":"7","key":"4798_CR24","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","volume":"111","author":"J de la Serna","year":"2008","unstructured":"de la Serna J, Montesinos P, Vellenga E, Ray\u00f3n C, Parody R, Le\u00f3n A et al (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood 111(7):3395\u20133402","journal-title":"Blood."},{"issue":"7","key":"4798_CR25","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2011.78","volume":"25","author":"S Lehmann","year":"2011","unstructured":"Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, M\u00f6llg\u00e5rd L et al (2011) Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia 25(7):1128\u20131134","journal-title":"Leukemia."},{"issue":"20","key":"4798_CR26","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood."},{"issue":"15","key":"4798_CR27","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, Estey EH, Lowenberg B, Naoe T et al (2019) Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 133(15):1630\u20131643","journal-title":"Blood."},{"issue":"1","key":"4798_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","volume":"145","author":"M Levi","year":"2009","unstructured":"Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 145(1):24\u201333","journal-title":"Br J Haematol."},{"key":"4798_CR29","doi-asserted-by":"crossref","unstructured":"Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S et al (2013) Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost","DOI":"10.1111\/jth.12155"},{"issue":"6","key":"4798_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129170","volume":"10","author":"M Wang","year":"2015","unstructured":"Wang M, Kou H, Deng J, Wang H, Guo T, Mei H et al (2015) Retrospective evaluation of new Chinese diagnostic scoring system for disseminated intravascular coagulation. PLoS One 10(6):e0129170","journal-title":"PLoS One."},{"issue":"1","key":"4798_CR31","doi-asserted-by":"publisher","first-page":"9057","DOI":"10.1038\/s41598-017-09190-5","volume":"7","author":"Y Wu","year":"2017","unstructured":"Wu Y, Luo L, Niu T, Han Y, Feng Y, Ding Q et al (2017) Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: a multicenter prospective study. Sci Rep 7(1):9057","journal-title":"Sci Rep."},{"issue":"6","key":"4798_CR32","first-page":"480","volume":"39","author":"YT Huang","year":"2018","unstructured":"Huang YT, Liu XF, Fu RF, Chen YF, Liu W, Xue F et al (2018) Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia. Zhonghua Xue Ye Xue Za Zhi 39(6):480\u2013484","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"issue":"8","key":"4798_CR33","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1182\/blood-2008-05-159632","volume":"112","author":"MA Sanz","year":"2008","unstructured":"Sanz MA, Montesinos P, Vellenga E, Ray\u00f3n C, de la Serna J, Parody R et al (2008) Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline mono-chemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. Blood 112(8):3130\u20133134","journal-title":"Blood."},{"issue":"4","key":"4798_CR34","first-page":"1192","volume":"94","author":"P Fenaux","year":"1999","unstructured":"Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E et al (1999) A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 94(4):1192\u20131200","journal-title":"The European APL Group. Blood."},{"issue":"6","key":"4798_CR35","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/bjh.13890","volume":"172","author":"F Lo-Coco","year":"2016","unstructured":"Lo-Coco F, Cicconi L, Breccia M (2016) Current standard treatment of adult acute promyelocytic leukemia. Br J Haematol 172(6):841\u2013854","journal-title":"Br J Haematol."},{"issue":"5","key":"4798_CR36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/0002-9343(86)90617-0","volume":"80","author":"HM Kantarjian","year":"1986","unstructured":"Kantarjian HM, Keating MJ, Walters RS, Estey EH, McCredie KB, Smith TL et al (1986) Acute promyelocytic leukemia. M.D. Anderson Hospital experience. Am J Med 80(5):789\u2013797","journal-title":"The American journal of medicine."},{"issue":"4","key":"4798_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/10428199109068072","volume":"4","author":"P Fenaux","year":"1991","unstructured":"Fenaux P, Pollet JP, Vandenbossche-Simon L, Morel P, Zandecki M, Jouet JP et al (1991) Treatment of acute promyelocytic leukemia: a report of 70 cases. Leuk Lymphoma 4(4):239\u2013248","journal-title":"Leukemia & lymphoma."},{"issue":"8","key":"4798_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.11622\/smedj.2014105","volume":"55","author":"F Karim","year":"2014","unstructured":"Karim F, Shaikh U, Adil SN, Khurshid M (2014) Clinical characteristics, outcome and early induction deaths in patients with acute promyelocytic leukemia: a five-year experience at a tertiary care center. Singapore Med J 55(8):443\u2013447","journal-title":"Singapore Med J."},{"issue":"1","key":"4798_CR39","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/j.clml.2018.08.001","volume":"19","author":"J Sun","year":"2019","unstructured":"Sun J, Zhu J, Zhou ZL, Yang X, Xie M et al (2019) Factors affecting early death and survival of patients with acute promyelocytic leukemia treated with ATRA-based therapy regimens. Clin Lymphoma Myeloma Leuk 19(1):e63\u2013e70","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"51","key":"4798_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009324","volume":"96","author":"F Xu","year":"2017","unstructured":"Xu F, Wang C, Yin C, Jiang X, Jiang L, Wang Z et al (2017) Analysis of early death in newly diagnosed acute promyelocytic leukemia patients. Medicine 96(51):e9324","journal-title":"Medicine."},{"issue":"1","key":"4798_CR41","first-page":"52","volume":"26","author":"LW Fang","year":"2018","unstructured":"Fang LW, Qin TJ, Xu ZF, Zhang Y, Zhang HL, Pan LJ et al (2018) Analysis of early-death and factors affecting prognosis of patients with acute promyelocytic leukemia. Zhongguo shi yan xue ye xue za zhi 26(1):52\u201357","journal-title":"Zhongguo shi yan xue ye xue za zhi."},{"issue":"8","key":"4798_CR42","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1080\/10428194.2020.1742910","volume":"61","author":"P Cai","year":"2020","unstructured":"Cai P, Wu Q, Wang Y, Yang X, Zhang X, Chen S (2020) An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia. Leuk Lymphoma 61(8):1989\u20131995","journal-title":"Leukemia & lymphoma."},{"issue":"12","key":"4798_CR43","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s00277-020-04245-6","volume":"99","author":"H Minamiguchi","year":"2020","unstructured":"Minamiguchi H, Fujita H, Atsuta Y, Asou N, Sakura T, Ueda Y et al (2020) Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia. Ann Hematol 99(12):2787\u20132800","journal-title":"Annals of hematology."},{"issue":"2","key":"4798_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.blre.2017.09.001","volume":"32","author":"AP Jillella","year":"2018","unstructured":"Jillella AP, Kota VK (2018) The global problem of early deaths in acute promyelocytic leukemia: a strategy to decrease induction mortality in the most curable leukemia. Blood Rev 32(2):89\u201395","journal-title":"Blood Rev."},{"issue":"4","key":"4798_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/ejh.13018","volume":"100","author":"W Cui","year":"2018","unstructured":"Cui W, Wang J, Nie RM, Zhao LL, Gao MQ, Zhu HM et al (2018) Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia. Europ J Hematol 100(4):344\u2013350","journal-title":"European journal of hematology."},{"issue":"13","key":"4798_CR46","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(15)00193-X","volume":"16","author":"AK Burnett","year":"2015","unstructured":"Burnett AK, Russell NH, Hills RK, Bowen D, Kell J, Knapper S et al (2015) Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukemia in all risk groups (AML17): results of a randomized, controlled, phase 3 trial. Lancet Oncol 16(13):1295\u20131305","journal-title":"The Lancet Oncology."},{"key":"4798_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2019.102351","volume":"79","author":"W Hou","year":"2019","unstructured":"Hou W, Zhang Y, Jin B, Cao W, Lu M, Yan L et al (2019) Factors affecting 111thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone. Blood Cells Mol Dis 79:102351","journal-title":"Blood Cells Mol Dis."},{"issue":"7","key":"4798_CR48","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.leukres.2010.11.008","volume":"35","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang Z, Jiang M, Dai L, Zhang W, Wu D et al (2011) The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leuk Res 35(7):879\u2013884","journal-title":"Leukemia research."},{"issue":"1","key":"4798_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/MPH.0000000000001280","volume":"41","author":"M Rajpurkar","year":"2019","unstructured":"Rajpurkar M, Alonzo TA, Wang YC, Gerbing RB, Gamis AS, Feusner JH et al (2019) Risk markers for significant bleeding and thrombosis in pediatric acute promyelocytic leukemia; report from the Children\u2019s Oncology Group study AAML0631. J Pediatr Hematol Oncol 41(1):51\u201355","journal-title":"J Pediatr Hematol Oncol."},{"issue":"5","key":"4798_CR50","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/09537104.2020.1799969","volume":"32","author":"T Chu","year":"2021","unstructured":"Chu T, Wang H, Lv X, Qi J, Tang Y, Fan Y et al (2021) Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia. Platelets 32(5):677\u2013683","journal-title":"Platelets."},{"issue":"1","key":"4798_CR51","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12032-013-0478-y","volume":"30","author":"M Mitrovic","year":"2013","unstructured":"Mitrovic M, Suvajdzic N, Bogdanovic A, Kurtovic NK, Sretenovic A, Elezovic I et al (2013) International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation \u2265 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemia. Med Oncol 30(1):478","journal-title":"Medical oncology (Northwood, London, England)."}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04798-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04798-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04798-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T23:36:08Z","timestamp":1726702568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04798-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["4798"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04798-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"5 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Boards of Trakya University, the Ethical Committee of Uludag University, and performed in compliance with the guidelines of the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}